Apogee Therapeutics, Inc. · NASDAQ:APGE
BlackRock, Inc. reported a 5.50% stake in Apogee Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc. reported a 5.50% stake in Apogee Therapeutics, Inc., 2,518,725 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 2,518,725
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.50% | 2,518,725 |
Source
Related
- Apogee Therapeutics, Inc.
- BlackRock, Inc.
- Apogee Therapeutics, Inc. shareholders
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026